Evidence supporting the use of: Curcumin
For the health condition: Inflammatory Bowel Disorders

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Curcumin, the principal curcuminoid derived from the spice turmeric (Curcuma longa), has been investigated for its therapeutic potential in Inflammatory Bowel Disorders (IBD), including Crohn’s disease and ulcerative colitis. The use of curcumin for IBD is justified by a growing body of scientific evidence, although it is not yet a mainstream treatment. Several preclinical studies have demonstrated that curcumin possesses anti-inflammatory, antioxidant, and immunomodulatory properties, which are highly relevant to the pathophysiology of IBD. It has been shown to inhibit key inflammatory mediators, such as NF-κB, TNF-α, and various interleukins, thereby reducing intestinal inflammation in animal models.

Clinical evidence, while still emerging, is promising but not definitive. Multiple randomized, placebo-controlled trials have suggested that curcumin, when used as an adjunct to conventional therapies (such as mesalamine), may help induce and maintain remission in patients with ulcerative colitis. For example, a 2006 double-blind, placebo-controlled trial published in Clinical Gastroenterology and Hepatology found that patients taking curcumin alongside standard therapy had significantly lower relapse rates than those on placebo. However, studies in Crohn's disease are fewer and less conclusive.

Overall, curcumin is supported by moderate-quality scientific evidence for use in ulcerative colitis, but more large-scale, long-term trials are needed to firmly establish efficacy and safety, particularly in Crohn’s disease. The evidence does not yet warrant routine use as a sole therapy, but it is a reasonable adjunctive option for some patients under medical supervision.

More about curcumin
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

2'-Fucosyllactose
akkermansia muciniphila
algal oil
aloe vera
alpha-glycosyl isoquercitrin
alpha-linolenic acid (ALA)
anthocyanins
bacillus clausii
bacillus subtilis
barberry
barley
beta caryophyllene
bifidobacterium bifidum
bifidobacterium breve
bifidobacterium infantis
bifidobacterium lactis
bifidobacterium longum
butyrate triglyceride
cat's claw
chamomile
citrus pectin
Coptis chinensis
turmeric
curcumin
dandelion
DHA (docosahexaeonic acid)
EPA (eicosapentaenoic acid)
fish oil
flaxseed
fructooligosaccharides (FOS)
inulin
isomalto-oligosaccharide
l-glutamine
lactobacillus brevis
lactobacillus casei
lactobacillus crispatus
lactobacillus fermentum
lactobacillus gasseri
lactobacillus lactis
lactobacillus paracasei
lactiplantibacillus plantarum
lactobacillus reuteri
lactobacillus rhamnosus
lactobacillus salivarius
lactococcus lactis
licorice root
luteolin
marshmallow
n-acetyl-glucosamine
n-acetyl-cysteine (NAC)
nicotinamide riboside
omega-3 fatty acids
pectin
peppermint oil
butyric acid
psyllium
reishi mushroom
saccharomyces boulardii
shiitake mushroom
slippery elm bark
specialized pro-resolving mediators (SPMs)
spirulina
streptococcus thermophilus
tributyrin
Urolithin A
vitamin C
vitamin D
vitamin D3
xylanase
xylooligosaccharides
zinc
bentonite
punarnava
rubia cordifolia
swertia
myrrh
algae
7,14-Hydroxy-Docosapentaenoic Acid
Apigenin
Andrographolide
Avocado
anthocyanidins
Acemannan
Arabinoxylan
Apocynin
Arctiin
Astragalin
Bifidobacterium
Bifidobacterium adolescentis
Brassica
Boswellic Acid
Butternut
Basidiomycota
Boswellia
Bacillus licheniformis
Bioflavonoids
Bifidobacterium animalis
Bacteria
Bifidobacteria
Bacillus
Cichoric acid
Cruciferous
Casticin
Celandine
Chirata
Cannabidiol
Enterococcus
Eicosapentaenoic Acid
Ellagitannin
Fiber